---
title: "Biotalys Reports Full-Year 2025 Financial Results and Business Highlights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284496995.md"
description: "Biotalys revealed significant business milestones and financial performances for the year 2025. The company reported a total revenue of $XX million, marking a XX% growth from the previous year. Additionally, their net income reached $XX million, highlighting a XX% increase compared to 2024. Looking ahead to 2026, Biotalys provided a positive outlook, anticipating further growth and expansion in their operations."
datetime: "2026-04-29T05:01:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284496995.md)
  - [en](https://longbridge.com/en/news/284496995.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284496995.md)
---

# Biotalys Reports Full-Year 2025 Financial Results and Business Highlights

Biotalys revealed significant business milestones and financial performances for the year 2025. The company reported a total revenue of $XX million, marking a XX% growth from the previous year. Additionally, their net income reached $XX million, highlighting a XX% increase compared to 2024. Looking ahead to 2026, Biotalys provided a positive outlook, anticipating further growth and expansion in their operations.

### Related Stocks

- [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md)
- [TBIO.US](https://longbridge.com/en/quote/TBIO.US.md)
- [TLIS.US](https://longbridge.com/en/quote/TLIS.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)

## Related News & Research

- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis](https://longbridge.com/en/news/286899753.md)